Breaking News:

U.S. SEC Mandates Chinese IPO Hopefuls to Provide Additional Risk Disclosures

News

Merck (NYSE: MRK) referred to as MSD outside U.S. and Canada, and Ridgeback Biotherapeutics last Friday made it known that Molnupiravir...

Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...

2021 has already witnessed many eventful FDA approvals. Not even the pandemic could stop biopharma’s historic ability to push prospects...

FDA approves first of its kind indication for chronic sleep disorder treatment The U.S. Food and Drug Administration on August 12 grants...

The U.S. Food and Drug Administration on July 28 announced the approval of the first interchangeable biosimilar insulin product aimed at...

FibroGen and AstraZeneca have been pushing for a better heart safety profile for their likely top-of-the-shelf anemia med roxadustat...

Have you ever imagined the possibility of using your smartphone with your brain? Like, being able to operate your device with your mind,...

Americans appreciate their vaccine makers. Cases in point? Moderna and Pfizer leapfrogged into the top 10 favorite companies in the U.S....

Nearly two-thirds of Americans now give the Pharma industry a thumbs up. According to The Harris Poll surveys, it is a massive reversal...

Exscientia plc, an Artificial Intelligence firm focused on discovering, designing and developing the highest quality medications in the...

Life sciences venture firm TP on Wednesday announced the launch of Replicate Bioscience in a bid to replicating the success RNA...

California-based RenovoRx, Inc. (NASDAQ: RNXT) has filed for offering up to 1.85 million units of securities in an initial public...